Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma
Clinical trial NCT05448677 · TERMINATED
Trial details
- NCT number
- NCT05448677
- Sponsor
- University Hospital, Grenoble
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2024-03-08
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.